Cargando…

Options and Obstacles for Designing a Universal Influenza Vaccine

Since the discovery of antibodies specific to a highly conserved stalk region of the influenza virus hemagglutinin (HA), eliciting such antibodies has been considered the key to developing a universal influenza vaccine that confers broad-spectrum protection against various influenza subtypes. To ach...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Yo Han, Seong, Baik Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147691/ https://www.ncbi.nlm.nih.gov/pubmed/25196381 http://dx.doi.org/10.3390/v6083159

Ejemplares similares

The Quest for a Truly Universal Influenza Vaccine
por: Jang, Yo Han, et al.
Publicado: (2019)

Principles underlying rational design of live attenuated influenza vaccines
por: Jang, Yo Han, et al.
Publicado: (2012)

Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses
por: Jang, Yo Han, et al.
Publicado: (2021)

Toward a universal influenza vaccine: from the perspective of protective efficacy
por: Jang, Yo Han, et al.
Publicado: (2013)

Cross-Protective Immune Responses Elicited by Live Attenuated Influenza Vaccines
por: Jang, Yo Han, et al.
Publicado: (2013)

Pan-Influenza A Protection by Prime–Boost Vaccination with Cold-Adapted Live-Attenuated Influenza Vaccine in a Mouse Model
por: Jang, Yo Han, et al.
Publicado: (2018)

Glycosylation of Hemagglutinin and Neuraminidase of Influenza A Virus as Signature for Ecological Spillover and Adaptation among Influenza Reservoirs
por: Kim, Paul, et al.
Publicado: (2018)

Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies
por: Hou, Yingying, et al.
Publicado: (2023)

A Host-Restricted Self-Attenuated Influenza Virus Provides Broad Pan-Influenza A Protection in a Mouse Model
por: Kim, Minjin, et al.
Publicado: (2021)

Universal routine HPV vaccination for young girls in Uganda: a review of opportunities and potential obstacles
por: Banura, Cecily, et al.
Publicado: (2012)

Non-specific Effect of Vaccines: Immediate Protection against Respiratory Syncytial Virus Infection by a Live Attenuated Influenza Vaccine
por: Lee, Young J., et al.
Publicado: (2018)

Obstacles and advances in SARS vaccine development
por: Taylor, Deborah R.
Publicado: (2006)

An obstacle to creating a universe in the laboratory
por: Farhi, E, et al.
Publicado: (1987)

Host Defense Mechanism-Based Rational Design of Live Vaccine
por: Jang, Yo Han, et al.
Publicado: (2013)

Universal Influenza Vaccines, a Dream to Be Realized Soon
por: Zhang, Han, et al.
Publicado: (2014)

Benefits, challenges and obstacles of adaptive clinical trial designs
por: Chow, Shein-Chung, et al.
Publicado: (2011)

Structural Insights for Anti-Influenza Vaccine Design
por: Han, Lifen, et al.
Publicado: (2019)

Progress in the Development of Universal Influenza Vaccines
por: Sun, Wenqiang, et al.
Publicado: (2020)

Influenza and Universal Vaccine Research in China
por: Li, Jiali, et al.
Publicado: (2022)

Vaccine Hesitancy: Obstacles and Challenges
por: Galagali, Preeti M., et al.
Publicado: (2022)

Obstacles and alternative options for cardiac rehabilitation in Nanjing, China: an exploratory study
por: Jin, Hong, et al.
Publicado: (2014)

Toward Novel Vaccines Against Tuberculosis: Current Hopes and Obstacles
por: Thaiss, Christoph A., et al.
Publicado: (2010)

Middle East respiratory syndrome: obstacles and prospects for vaccine development
por: Papaneri, Amy B, et al.
Publicado: (2015)

Diagnostic applications and therapeutic option of Cascade CRISPR/Cas in the modulation of miRNA in diverse cancers: promises and obstacles
por: Alinejad, Tahereh, et al.
Publicado: (2023)

Prospects and Challenges in the Development of Universal Influenza Vaccines
por: Madsen, Anders, et al.
Publicado: (2020)

Targeting Antigens for Universal Influenza Vaccine Development
por: Nguyen, Quyen-Thi, et al.
Publicado: (2021)

Challenges and Obstacles for a Bouncing Universe in Brane Models
por: Kanti, Panagiota, et al.
Publicado: (2003)

Virtual conference design: features and obstacles
por: Hurst, William, et al.
Publicado: (2022)

Strategies Targeting Hemagglutinin as a Universal Influenza Vaccine
por: Bullard, Brianna L., et al.
Publicado: (2021)

Progress towards the Development of a Universal Influenza Vaccine
por: Wang, Wen-Chien, et al.
Publicado: (2022)

Better influenza vaccines: an industry perspective
por: Chen, Juine-Ruey, et al.
Publicado: (2020)

The Preventive Obstacle, etc.
Publicado: (1870)

A chimeric thermostable M2e and H3 stalk-based universal influenza A virus vaccine
por: Subbiah, Jeeva, et al.
Publicado: (2022)

Prospects of HA-Based Universal Influenza Vaccine
por: Hashem, Anwar M.
Publicado: (2015)

Nano/microparticle Formulations for Universal Influenza Vaccines
por: Hendy, Dylan A., et al.
Publicado: (2022)

Computational Approaches and Challenges to Developing Universal Influenza Vaccines
por: Qiu, Xueting, et al.
Publicado: (2019)

Influenza–Host Interplay and Strategies for Universal Vaccine Development
por: Hwang, Hye Suk, et al.
Publicado: (2020)

Overcoming Obstacles in Liquid Biopsy Developments for Prostate Cancer
por: Jang, Albert, et al.
Publicado: (2022)

Immune Suppression in Tumors as a Surmountable Obstacle to Clinical Efficacy of Cancer Vaccines
por: Wieërs, Grégoire, et al.
Publicado: (2011)

Towards the knowledge-based design of universal influenza epitope ensemble vaccines
por: Sheikh, Qamar M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7vln8j79t8mssoqvfhh6ds57dh